Kathryn E. Foulds

National Institutes of Health — United States

Immunology and Microbiology · Life Sciences

35h-index5.7kcitations93works14.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(34), Immunotherapy and Immune Responses(24), SARS-CoV-2 and COVID-19 Research(22), Immune Cell Function and Interaction(22), T-cell and B-cell Immunology(18)

Publications92 total

Antibody prophylaxis may mask subclinical SIV infections in macaques
Nature·2025· 8 citedOpen Access
SIV monoclonal antibody administration spanning treatment interruption in macaques delays viral rebound and selects escape variants
Proceedings of the National Academy of Sciences·2025· 1 citedOpen Access
Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques
Cell·2024· 22 citedOpen Access
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates
Nature Immunology·2024· 33 citedOpen Access
Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways
Nature Communications·2024· 1 citedOpen Access
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines
Nature·2024· 71 citedOpen Access
Escalating Dose Immunization Regimen in Non-Human Primates to Improve Immunogen-Specific Responses
The Journal of Immunology·2024
Frequency-potency analysis of IgG+ memory B cells delineates neutralizing antibody responses at single-cell resolution
Cell Reports·2024· 2 citedOpen Access
A Single-shot ChAd3 Vaccine Provides Protection from Intramuscular and Aerosol Sudan Virus Exposure
2024· 2 citedOpen Access
Systems immunology of transcriptional responses to viral infection identifies conserved antiviral pathways across macaques and humans
Cell Reports·2024· 4 citedOpen Access
Interaction dynamics between innate and adaptive immune cells responding to SARS-CoV-2 vaccination in non-human primates
Nature Communications·2023· 11 citedOpen Access
Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates
2023· 4 citedOpen Access
Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman Primates
2023· 9 citedOpen Access
Immune Activation Profiles Elicited by Distinct, Repeated TLR Agonist Infusions in Rhesus Macaques
The Journal of Immunology·2023· 3 citedOpen Access
Investigation of the impact of clonal hematopoiesis on severity and pathophysiology of COVID-19 in rhesus macaques
Frontiers in Veterinary Science·2023Open Access
Systems immunology of transcriptional responses to viral infection identifies conserved antiviral pathways across macaques and humans
2023Open Access
RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways
2023· 1 citedOpen Access
Serial intravascular staining reveals altered T cell trafficking in aged and SIV+ rhesus macaques
The Journal of Immunology·2023Open Access
Rhesus macaque Bcl-6/Bcl-xL B cell immortalization: Discovery of HIV-1 neutralizing antibodies from lymph node
Journal of Immunological Methods·2023· 2 cited
Investigation of the Impact of Clonal Hematopoiesis on Severity and Pathophysiology of COVID-19 in Rhesus Macaques
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Mario Roederer(26), John-Paul Todd(19), John R. Mascola(18), Robert A. Seder(17), Mitzi M. Donaldson(14), Daniel C. Douek(14), Peter D. Kwong(13), Lingshu Wang(12), Martha Nason(12), Adrian B. McDermott(12), Nancy J. Sullivan(12), David C. Montefiori(12), Barbara J. Flynn(11), Hanné Andersen(11), Laurent Pessaint(11), Alan Dodson(11), Mark G. Lewis(11), Matthew Gagné(11), Shayne F. Andrew(11), Kizzmekia S. Corbett(10)